ACE Inhibitors, Angiotensin Receptor Blockers May Reduce Migraine Frequency
Lipophilic angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may effectively reduce migraine frequency.
All articles by Hannah Dellabella
Updated Criteria for Headache Attributed to Transient Ischemic Attacks
Researchers have proposed an update to the International Classification of Headache Disorders-3 criteria for headache attributed to transient ischemic attacks.
CB2 Receptor Agonist Effective for Neuropathic Pain in Preclinical Studies
CNTX-6016, a highly-selective cannabinoid receptor type 2 agonist, was found to provide adequate analgesia in preclinical models of neuropathic pain.
Left Atrial Appendage Electrical Isolation Increases Stroke Risk
A significantly increased stroke risk was identified following left atrial appendage electrical isolation; however, the risk could be reduced by oral anticoagulation or placement of a left atrial appendage occlusion device.
Smartphone-Based Progressive Muscle Relaxation May Reduce Monthly Headache Days in Migraine
The use of a smartphone-based progressive muscle relaxation was found to be associated with a reduction in monthly headache days and depression scores in patients with migraine.
Opioid Prescription Trends for Migraine in Youth in the ED
The use of opioids in emergency departments for the management of migraine pain in adolescents and young adults was found to be common.
Risks for Cardiovascular, Cerebrovascular Events in Individuals Taking Migraine Prophylactics
Individuals taking certain prophylactic migraine treatments were found to be at increased risk for cardiovascular and cerebrovascular events.
Neurodegenerative Conditions Distinguishable by Plasma Neurofilament Light
Plasma neurofilament light concentrations may be able to distinguish several neurodegenerative conditions. Results indicate that NfL may be promising as a clinical tool or for use in clinical trials.
Alzheimer Disease, Dementia Linked to Increased Seizure Risk
Patients with dementia or Alzheimer disease (AD) have a significantly increased risk for seizures compared with patients without AD or dementia.
Red Blood Cell Biomarker May Aid in Diagnosis of Early Alzheimer Disease
The level of α-syn heteroaggregates in red blood cells may be a tool for the diagnostic work-up in early Alzheimer disease diagnosis.
Next post in Alzheimer's Disease and Dementia
